This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 93/4/1482    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Anuurad, E. Articles by Berglund, L. PubMed PubMed Citation Articles by Anuurad, E. Articles by Berglund, L. Related Collections Lipid

High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans

Department of Medicine (E.A., A.C., L.B.), University of California, Davis, Sacramento, California 95817; Department of Medicine (J.R.), Columbia University, New York, New York 10027; Department of Pathology (R.P.T.), University of Vermont, Burlington, Vermont 05405; Department of Community and Preventive Medicine (T.A.P.), University of Rochester, Rochester, New York 14627; and VA Northern California Health Care System (L.B.), Sacramento, California 95655

Address all correspondence and requests for reprints to: Lars Berglund, M.D., Department of Medicine, University of California, Davis, UCD Medical Center, Clinical and Translation Science Center, 2921 Stockton Boulevard, Suite 1400, Sacramento, California 95817. E-mail: lars.berglund{at}ucdmc.ucdavis.edu.

Background: A role of inflammation for cardiovascular disease (CVD) is established. Lipoprotein(a) [Lp(a)] is an independent CVD risk factor where plasma levels are determined by the apolipoprotein(a) [apo(a)] gene, which contains inflammatory response elements.

Design: We investigated the effect of inflammation on allele-specific apo(a) levels in African-Americans and Caucasians. We determined Lp(a) levels, apo(a) sizes, allele-specific apo(a) levels, fibrinogen and C-reactive protein (CRP) levels in 167 African-Americans and 259 Caucasians.

Results: Lp(a) levels were increased among African-Americans with higher vs. lower levels of CRP [<3 vs. 3 mg/liter (143 vs. 108 nmol/liter), P = 0.009] or fibrinogen (<340 vs. 340 mg/liter, P = 0.002). We next analyzed allele-specific apo(a) levels for different apo(a) sizes. No differences in allele-specific apo(a) levels across CRP or fibrinogen groups were seen among African-Americans or Caucasians for small apo(a) sizes (<22 kringle 4 repeats). Allele-specific apo(a) levels for medium apo(a) sizes (22–30 kringle 4 repeats) were significantly higher among African-Americans, with high levels of CRP or fibrinogen compared with those with low levels (88 vs. 67 nmol/liter, P = 0.014, and 91 vs. 59 nmol/liter, P < 0.0001, respectively). No difference was found for Caucasians.

Conclusions: Increased levels of CRP or fibrinogen are associated with higher allele-specific medium-sized apo(a) levels in African-Americans but not in Caucasians. These findings indicate that proinflammatory conditions result in a selective increase in medium-sized apo(a) levels in African-Americans and suggest that inflammation-associated events may contribute to the interethnic difference in Lp(a) levels between African-Americans and Caucasians.